申请人:British Technology Group Limited
公开号:US05543422A1
公开(公告)日:1996-08-06
Heterocyclic amines of the formula Ar-X-A-NR.sup.1 R.sup.2 wherein Ar is a bicyclic or tricyclic aromatic group which is unsubstituted or which bears one or more substituents selected from halo, nitro and cyano groups and alkyl and alkoxy groups each of up to 4 carbon atoms; wherein X is a direct link or is --O--, --S--, --SO-- or --SO.sub.2 -- or has the formula --C(R.sup.3).dbd.CH-- wherein R.sup.3 is hydrogen or alkyl of up to 4 carbon atoms; wherein A is straight or branched alkylene or alkenylene of 3 to 8 carbon atoms which may be interrupted by --O--, --S-- or --NH--; and wherein NR.sup.1 R.sup.2 is a cyclic amino group; or a pharmaceutically acceptable acid addition salt thereof, are of value for therapeutic use, particularly in the treatment of myocardial ischaemia and hypertension and in the treatment of fungal infections.
具有Ar-X-A-NR.sup.1 R.sup.2化学式的杂环胺,其中Ar是一个未取代或带有一个或多个卤素、硝基和氰基以及每个长达4个碳原子的烷基和烷氧基取代基所选的双环或三环芳香基;其中X是直链或为--O--、--S--、--SO--或--SO.sub.2--或具有--C(R.sup.3).dbd.CH--化学式,其中R.sup.3是长达4个碳原子的氢或烷基;其中A是3到8个碳原子的直链或支链烷基或烯烃基,可以被--O--、--S--或--NH--中断;其中NR.sup.1 R.sup.2是一个环状氨基;或其药用可接受的酸盐,对于治疗用途具有价值,特别是在治疗心肌缺血和高血压以及治疗真菌感染方面。